SQI Diagnostics to Present at the European Bioanalysis Forum Open Symposium November 14-16, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has been chosen to present its Ig_PLEX multiplexing technology and its accompanying platforms at the European Bioanalysis Forum (EBF) Open Symposium being held in Barcelona, Spain, November 14-16, 2012. The SQiDlite™ system, one of SQI Diagnostics’ platforms to be highlighted, was developed to address the multiplexed testing needs of clinical diagnostic laboratories, pharmaceutical drug development and Contract Research Organizations (CRO) performing bioanalytical and immunogenicity testing.